Magnus Heystek: Investing in ‘cheap’ JSE is still a bad idea, no matter how you slice it
Magnus Heystek has been called “Dr Doom” for consistently warning investors about the JSE’s underperformance. Lately his critics have gone quiet.
Magnus Heystek has been called “Dr Doom” for consistently warning investors about the JSE’s underperformance. Lately his critics have gone quiet.
The banking power base balance in sub-Saharan Africa has shifted over the last 12 months – particularly in the traditional banking space where investors are hungry for good credits.